Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 5 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 4/24/2011 2:15:52 AM : Outperform Start Price: $6.20 FLML Score: -28.17

nanobiotech good technicals

Featured Broker Partners


Advertisement